Axel Finckh

Geneve, GE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 201 publications

Risk-benefit considerations for antirheumatic drug use in pregnancy, breastfeeding, and male preconception: expert perspectives.

Risk-benefit considerations for antirheumatic drug use in pregnancy, breastfeeding, and male preconception: expert perspectives.

Journal: EULAR rheumatology open

Published: August 01, 2026

Anatomy of a failure: a retrospective evaluation of a cognitive bias modification intervention to promote physical activity in cardiac rehabilitation.

Anatomy of a failure: a retrospective evaluation of a cognitive bias modification intervention to promote physical activity in cardiac rehabilitation.

Journal: BMJ open

Published: April 29, 2026

Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management Registry.

Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management Registry.

Journal: RMD open

Published: April 08, 2026

Title Not Found

Title Not Found

Journal: Revue medicale suisse

Published: March 11, 2026

Rheumatoid arthritis pathogenesis. From susceptibility to autoimmunity, and arthritis

Rheumatoid arthritis pathogenesis. From susceptibility to autoimmunity, and arthritis

Journal: Revue medicale suisse

Published: March 11, 2026

Influence of the shared epitope on the effectiveness of biologic antirheumatic agents in European patients with rheumatoid arthritis.

Influence of the shared epitope on the effectiveness of biologic antirheumatic agents in European patients with rheumatoid arthritis.

Journal: RMD open

Published: January 29, 2026

Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.

Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.

Journal: BMJ open

Published: December 15, 2025

Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis: Insights From JAK, an International Registry Collaboration.

Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis: Insights From JAK, an International Registry Collaboration.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 20, 2025

Evolution of Janus Kinase inhibitors (JAKi) prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study): effect of regulatory warnings.

Evolution of Janus Kinase inhibitors (JAKi) prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study): effect of regulatory warnings.

Journal: Seminars in arthritis and rheumatism

Published: October 02, 2025

Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis.

Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis.

Journal: RMD open

Published: September 22, 2025

The epidemiology of RA.

The epidemiology of RA.

Journal: Nature reviews. Rheumatology

Published: September 09, 2025

Persistence and effectiveness of upadacitinib and TNFi for rheumatoid arthritis using pooled data from Canadian and Swiss registries.

Persistence and effectiveness of upadacitinib and TNFi for rheumatoid arthritis using pooled data from Canadian and Swiss registries.

Journal: Rheumatology (Oxford, England)

Published: August 27, 2025

Showing 1-12 of 201

Last Updated: 09/26/2026